May 9,2025
June 9, 2025
This week’s newsletter included:
- Nelson Labs Celebrates Its 40th Anniversary
- Federal Reserve Learns About Life Sciences in Utah
- Varex Imaging Presented Global Pacesetter Award at Crossroads of the World Summit
- Crossroads of the World Summit Present by Zions Bank and World Trade Center Utah
- In Memory of Ping Fong, Jr.
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Utah Ranked #1 State in America for Third Consecutive Year
- Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility in West Valley
- Recursion’s “Evening of Hope”
- Myriad Genetics Announces Risk Score Published in JCO Precision Oncology
- Merit Medical Releases 12-Month Efficacy Results for Single-Arm Arteriovenous Graft (AVG) Cohort of WRAPSODY Arteriovenous Efficacy (WAVE) Trial
- Merit Medical Announces Health Canada Approval of the WRAPSODY
- RAPS Utah Announces 2o25 Leadership Team
- Sera Prognotics Appoints Lee Anderson as Chief Commercial Officer
- Don’t Miss BioUtah’s Exclusive Biosphere Magazine Promotional Opportunity
- Nominations Now Open: 2025 Innovations in Regulatory Science & Policy Awards
- 2025 Utah Business Fast 50 Registration
- Utah Business: Nominations for Most Influential Women Open
- Utah Business: Nominations for Innovation Awards Open
Featured BioUtah Elite Bronze Member: Vertex Pharmaceuticals
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize